Cargando…

Neurotoxic Antibodies against the Prion Protein Do Not Trigger Prion Replication

Prions are the infectious agents causing transmissible spongiform encephalopathies (TSE), progressive, inexorably lethal neurological diseases. Antibodies targeting the globular domain (GD) of the cellular prion protein PrP(C) trigger a neurotoxic syndrome morphologically and molecularly similar to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frontzek, Karl, Pfammatter, Manuela, Sorce, Silvia, Senatore, Assunta, Schwarz, Petra, Moos, Rita, Frauenknecht, Katrin, Hornemann, Simone, Aguzzi, Adriano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042507/ https://www.ncbi.nlm.nih.gov/pubmed/27684562 http://dx.doi.org/10.1371/journal.pone.0163601

Ejemplares similares

Glial activation in prion diseases is selectively triggered by neuronal PrP(Sc)
por: Lakkaraju, Asvin K. K., et al.
Publicado: (2022)

Protective anti‐prion antibodies in human immunoglobulin repertoires
por: Senatore, Assunta, et al.
Publicado: (2020)

Prion Infections and Anti-PrP Antibodies Trigger Converging Neurotoxic Pathways
por: Herrmann, Uli S., et al.
Publicado: (2015)

Genome-wide transcriptomics identifies an early preclinical signature of prion infection
por: Sorce, Silvia, et al.
Publicado: (2020)

Prion Pathogenesis in the Absence of NLRP3/ASC Inflammasomes
por: Nuvolone, Mario, et al.
Publicado: (2015)

Brain aging is faithfully modelled in organotypic brain slices and accelerated by prions
por: Liu, Yingjun, et al.
Publicado: (2022)

The biological function of the cellular prion protein: an update
por: Wulf, Marie-Angela, et al.
Publicado: (2017)

Inhibition of group-I metabotropic glutamate receptors protects against prion toxicity
por: Goniotaki, Despoina, et al.
Publicado: (2017)

Author Correction: Brain aging is faithfully modelled in organotypic brain slices and accelerated by prions
por: Liu, Yingjun, et al.
Publicado: (2022)

A neuroprotective role for microglia in prion diseases
por: Zhu, Caihong, et al.
Publicado: (2016)

A conformational switch controlling the toxicity of the prion protein
por: Frontzek, Karl, et al.
Publicado: (2022)

Prion pathogenesis is unaltered in the absence of SIRPα-mediated "don't-eat-me" signaling
por: Nuvolone, Mario, et al.
Publicado: (2017)

Isolation of infectious, non-fibrillar and oligomeric prions from a genetic prion disease
por: Vanni, Ilaria, et al.
Publicado: (2020)

The Role of the NADPH Oxidase NOX2 in Prion Pathogenesis
por: Sorce, Silvia, et al.
Publicado: (2014)

Studies on Prion Replication in Spleen
por: Raeber, Alex J., et al.
Publicado: (2001)

Loss of PIKfyve drives the spongiform degeneration in prion diseases
por: Lakkaraju, Asvin K K, et al.
Publicado: (2021)

Prion infection, transmission, and cytopathology modeled in a low-biohazard human cell line
por: Avar, Merve, et al.
Publicado: (2020)

SARM1 deficiency up-regulates XAF1, promotes neuronal apoptosis, and accelerates prion disease
por: Zhu, Caihong, et al.
Publicado: (2019)

Protease resistance of infectious prions is suppressed by removal of a single atom in the cellular prion protein
por: Leske, Henning, et al.
Publicado: (2017)

Differential Toxicity of Antibodies to the Prion Protein
por: Reimann, Regina R., et al.
Publicado: (2016)

Sympathetic Prions
por: Glatzel, Markus, et al.
Publicado: (2001)

A bispecific immunotweezer prevents soluble PrP oligomers and abolishes prion toxicity
por: Bardelli, Marco, et al.
Publicado: (2018)

Enhanced detection of prion infectivity from blood by preanalytical enrichment with peptoid-conjugated beads
por: Hornemann, Simone, et al.
Publicado: (2019)

The ultrastructure of infectious L-type bovine spongiform encephalopathy prions constrains molecular models
por: Kamali-Jamil, Razieh, et al.
Publicado: (2021)

Soluble dimeric prion protein ligand activates Adgrg6 receptor but does not rescue early signs of demyelination in PrP-deficient mice
por: Henzi, Anna, et al.
Publicado: (2020)

Five Questions on Prion Diseases
por: Aguzzi, Adriano, et al.
Publicado: (2012)

Cystatin F is a biomarker of prion pathogenesis in mice
por: Nuvolone, Mario, et al.
Publicado: (2017)

Lymphotoxin, but Not TNF, Is Required for Prion Invasion of Lymph Nodes
por: O'Connor, Tracy, et al.
Publicado: (2012)

The Comprehensive Native Interactome of a Fully Functional Tagged Prion Protein
por: Rutishauser, Dorothea, et al.
Publicado: (2009)

Prion protein and Aβ-related synaptic toxicity impairment
por: Calella, Anna Maria, et al.
Publicado: (2010)

Mechanism of misfolding of the human prion protein revealed by a pathological mutation
por: Sanz-Hernández, Máximo, et al.
Publicado: (2021)

Ribosomal profiling during prion disease uncovers progressive translational derangement in glia but not in neurons
por: Scheckel, Claudia, et al.
Publicado: (2020)

A role for astroglia in prion diseases
por: Aguzzi, Adriano, et al.
Publicado: (2017)

Engulfment of cerebral apoptotic bodies controls the course of prion disease in a mouse strain–dependent manner
por: Kranich, Jan, et al.
Publicado: (2010)

Lymphocyte activation gene 3 (Lag3) expression is increased in prion infections but does not modify disease progression
por: Liu, Yingjun, et al.
Publicado: (2018)

Strictly co-isogenic C57BL/6J-Prnp(−/−) mice: A rigorous resource for prion science
por: Nuvolone, Mario, et al.
Publicado: (2016)

Unaltered Prion Pathogenesis in a Mouse Model of High-Fat Diet-Induced Insulin Resistance
por: Zhu, Caihong, et al.
Publicado: (2015)

Recent developments in the pathogenesis, diagnosis, and therapy of prion diseases
por: Aguzzi, Adriano
Publicado: (2001)

Neurotoxicity of Prion Peptides Mimicking the Central Domain of the Cellular Prion Protein
por: Vilches, Silvia, et al.
Publicado: (2013)

Synaptic Dysfunction in Prion Diseases: A Trafficking Problem?
por: Senatore, Assunta, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_hq592lgmvts4u527vs4ancset5